Submit Responses via Email to:

Paul Gruen, Implementation Consultant

Bree Collaborative

Implementation Survey: Medical Groups

INTRODUCTION

In 2011, the Washington State Legislature established the Dr. Robert Bree Collaborative so that public and private health care stakeholders would have the opportunity to identify specific ways to improve health care quality, outcomes, and affordability in Washington State. These stakeholders are appointed by the Governor as Collaborative members and represent public health care purchasers for Washington State, private health care purchasers (employers and union trusts), health plans, physicians and other health care providers, hospitals, and quality improvement organizations.

Work groups review evidence-based guidelines and seek consensus from the Collaborative on selected topics. Recommendations are sent to the Washington State Health Care Authority for approval, in order to guide the type of health care provided to Medicaid enrollees, state employees, and other groups. Other healthcare purchasers and providers are encouraged to adopt recommendations into their own operations and reimbursement contracts where appropriate.

We are currently working to measure and facilitate adoption of our recommendations across Washington State. This survey is meant to assess adoption of our recommendations by medical groups.

SCALE

We are measuring adoption of specific recommendations using 0-3 point scale, self-assessed by each medical group.

0 - No action taken /
  • No leadership awareness of Bree Collaborative Topics

  • No team formed

1 - Actively considering adoption /
  • Bree topics, aims and components have been discussed

  • Education, assessment, information gathering

  • Changes planned but not tested

  • Information gathering and baseline measurement begun.

2 - Some/similar adoption /
  • Initial test cycles completed for more than one element

  • Quality metrics & data available demonstrating adoption/effectiveness

  • Other similar (Bree-like) changes adopted for this topic

3 - Full adoption /
  • Changes implemented in all areas

  • All components integrated into care process (i.e. orders, etc.)

  • Partial or complete closure of gap between baseline & target outcomes

RESULTS

Results will be collected, compiled and shared with responding medical groups, Bree Collaborative members, workgroup members, and with others in Washington State.

I. Your Organization

Name of Medical Group:
Person Completing Survey:
Title:
Phone:
Email:

II. Oncology Care

Read the full report here

0 -No action taken; 1 -Actively considering adoption; 2 -Some/similar adoption; 3 -Full adoption

ASSESSMENT SCORE
The American Society of Clinical Oncology’s (ASCO) Choosing Wisely recommendations are followed including:
PET [positron emission tomography], CT [computed tomography] and radionuclide bone scans are not used in the staging of early prostate cancer at low risk of spreading
PET, CT, and radionuclide bone scans are not used in the staging of early breast cancer that is at low risk of spreading
Palliative care is offered alongside active anti-cancer care, as needed
Oncology care is aligned with a patient’s individual goals and values and follows the American Society of Clinical Oncology’s (ASCO) position statement of key elements for individualized cancer care
Patients are apprised of the harms, benefits, evidence, and potential impact of chemotherapy, radiation, molecular therapy, immunotherapy, and surgery at all stages in their illness trajectory
Goals of treatment are discussed at beginning of treatment
Additional Comments: